This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
Picrorhiza protects the liver primarily through its active compounds kutkin, picroside I, and picroside II, which demonstrate potent antioxidant and anti-inflammatory properties. These iridoid glycosides help stabilize hepatocyte membranes, inhibit lipid peroxidation, and stimulate liver cell regeneration. Research suggests Picrorhiza modulates immune responses in hepatic tissue and may inhibit pro-inflammatory cytokines. Some comparative studies indicate it provides stronger hepatoprotective effects than silymarin from milk thistle, though evidence remains preliminary (Level C). The herb also functions as a digestive bitter, promoting bile flow and supporting overall digestive function.
Does Picrorhiza root interact with any medications?
Picrorhiza may interact with immunosuppressive medications due to its immune-stimulating properties, potentially reducing drug effectiveness. The herb could theoretically affect medications metabolized by hepatic enzymes, though specific interaction studies are limited. Patients taking antidiabetic medications should exercise caution, as Picrorhiza may influence blood glucose levels. Individuals on immunosuppressants following organ transplantation should avoid this herb entirely. Clinical interaction data remains sparse (Level C evidence), so consult a qualified healthcare provider before combining Picrorhiza with prescription medications.
What is the recommended dosage for Picrorhiza extract?
The standard adult dosage for Picrorhiza kurroa is 400-600mg daily of a standardized extract containing picroside I and picroside II. Traditional Ayurvedic preparations may use powdered root or decoctions, though standardized extracts offer more consistent therapeutic dosing. Picrorhiza is typically taken with food to minimize potential gastrointestinal side effects. Duration of use should be guided by a qualified practitioner, as long-term safety data remains limited. Starting with lower doses to assess tolerance before increasing to the full recommended amount is advisable.
Is Picrorhiza safe to take during pregnancy?
Picrorhiza kurroa is considered unsafe during pregnancy and must be avoided. The herb possesses emmenagogue properties that may stimulate uterine contractions and potentially cause miscarriage. Safety during breastfeeding has not been established, so use while nursing is not recommended. Women of childbearing age should use reliable contraception while taking Picrorhiza. Pregnant individuals seeking liver support should consult their healthcare provider about safer alternatives such as milk thistle (silymarin), which has a more established safety profile during pregnancy.
Can people with autoimmune diseases take Picrorhiza?
Picrorhiza is contraindicated for individuals with autoimmune diseases including lupus, rheumatoid arthritis, and multiple sclerosis. The herb stimulates immune function, which may exacerbate autoimmune conditions by increasing immune activity against the body's own tissues. Patients with inflammatory bowel disease (IBD), such as Crohn's disease or ulcerative colitis, should also avoid Picrorhiza, as it may worsen gastrointestinal inflammation and cause diarrhea. Those with autoimmune conditions seeking liver support should work with a qualified healthcare provider to identify appropriate alternatives.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Picrorhiza kurrooa (Kutki) is an endangered Himalayan herb recognized in Ayurveda for its therapeutic potential, particularly its hepatoprotective and antioxidant properties [PMID:33797375, PMID:38099237].
Background
Picrorhiza kurrooa (also known as Kutki or Indian gentian) is a small perennial herb from the Plantaginaceae (or Scrophulariaceae) family found in the Himalayan region at altitudes between 3,000-5,000 meters [PMID:33797375, PMID:11410077, PMID:34294764]. It is currently classified as an endangered species due to over-harvesting and habitat destruction [PMID:33797375, PMID:34294764, PMID:36184806].
Traditional uses
In the Ayurvedic system, it has been traditionally used to treat liver and upper respiratory tract disorders, reduce fevers, treat dyspepsia, chronic diarrhea, and scorpion stings [PMID:11410077]. Other folk uses include chronic constipation, skin problems, burning sensations, jaundice, heart problems, breathing issues, digestion, allergy, tuberculosis, blood-related problems, prediabetes, and obesity [PMID:36500409].
Active compounds
The primary bioactive constituents are monoterpenoid iridoid glycosides known as picrosides (including picroside I and II) [PMID:33797375, PMID:34294764, PMID:32554175]. Other identified compounds include apocynin (4-hydroxy-3-methoxy-acetophenone), cucurbitacin glycosides, flavonoids, alkaloids, phenolics, and tannins [PMID:22202030, PMID:38099237, PMID:2616673].
Mechanism of action
Apocynin acts as an inhibitor of nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase, which prevents the translocation of the p47phox subunit to the plasma membrane [PMID:22202030, PMID:33689526]. The herb also exhibits antioxidant and anti-inflammatory activities, and some isolates decrease cytotoxicity in hepatocytes and nitric oxide production in macrophages [PMID:33797375, PMID:37258151].
Clinical evidence
Evidence DHepatotoxicity/Liver Injury
Methanol extracts of rhizomes, specifically picroside II, androsin, and 4-hydroxy-3-methoxyacetophenone, showed hepatoprotective effects against D-GalN/LPS-induced liver injury in mice [PMID:37258151].
Evidence DDiabetes
Oral administration of aqueous and methanol extracts of rhizomes in alloxan-induced diabetic rats significantly reduced blood glucose and glycosylated haemoglobin while increasing plasma insulin [PMID:23105761].
Evidence DNephrotoxicity
Picrorhiza kurroa demonstrated nephroprotective qualities in mice treated with nimesulide to induce nephrotoxicity [PMID:29938416].
Evidence CNeurodegeneration
Apocynin, a constituent of P. kurroa, is regarded as having neuroprotective effects in the prevention and treatment of neurodegenerative disorders [PMID:22202030].
Evidence summary
The current evidence is primarily based on in vitro studies, animal models (mice and rats), and literature reviews. There is strong preclinical evidence for hepatoprotective and antioxidant activities, but high-level clinical trial data (RCTs) are lacking in the provided abstracts.
PubMed sources
1.PMID: 33797375 (2021) — Advances in Ethnobotany, Synthetic Phytochemistry and Pharmacology of Endangered Herb Picrorhiza kurroa (Kutki): A Comprehensive Review (2010-2020). · Mini reviews in medicinal chemistry
2.PMID: 22202030 (2012) — The neuroprotective effects of apocynin. · Frontiers in bioscience (Elite edition)
3.PMID: 38099237 (2023) — Comparative Study on the Biochemical Profile and Antioxidant Activity of Picrorhiza kurrooa Rolye ex Benth. Obtained from Uttarakhand. · Evidence-based complementary and alternative medicine : eCAM
4.PMID: 2616673 (1989) — New cucurbitacin glycosides from Picrorhiza kurrooa. · Planta medica
5.PMID: 34294764 (2021) — The first draft genome of Picrorhiza kurrooa, an endangered medicinal herb from Himalayas. · Scientific reports
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 11410077 (2001) — Picrorhiza kurroa. Monograph. · Alternative medicine review : a journal of clinical therapeutic
7.PMID: 24057251 (2013) — Components of antioxidant system of Picrorhiza kurrooa exhibit different spatio-temporal behavior. · Molecular biology reports
8.PMID: 24973882 (2014) — Differential proteomics of Picrorhiza kurrooa Royle ex Benth. in response to dark stress. · Molecular biology reports
9.PMID: 33689526 (2021) — Pharmacology of apocynin: a natural acetophenone. · Drug metabolism reviews
10.PMID: 22593921 (2011) — Pharmacology and chemistry of a potent hepatoprotective compound Picroliv isolated from the roots and rhizomes of Picrorhiza kurroa royle ex benth. (kutki). · Current pharmaceutical biotechnology
11.PMID: 24979341 (2014) — A phenylalanine ammonia-lyase ortholog (PkPAL1) from Picrorhiza kurrooa Royle ex. Benth: molecular cloning, promoter analysis and response to biotic and abiotic elicitors. · Gene
12.PMID: 37811959 (2023) — Endomicrobiome of in vitro and natural plants deciphering the endophytes-associated secondary metabolite biosynthesis in Picrorhiza kurrooa, a Himalayan medicinal herb. · Microbiology spectrum
13.PMID: 35558871 (2022) — Phytochemical Screening, Antioxidant, and Inhibition Activity of Picrorhiza kurroa Against α-Amylase and α-Glucosidase. · Dose-response : a publication of International Hormesis Society
14.PMID: 35659739 (2023) — Picrorhiza kurroa, Royle ex Benth:Traditional uses, phytopharmacology, and translational potential in therapy of fatty liver disease. · Journal of Ayurveda and integrative medicine
15.PMID: 42116193 (2026) — Unravelling the fungal endomicrobiome of Picrorhiza kurrooa for increasing in-planta picroside biosynthesis using endophytic Trichoderma harzianum PKRF1. · Environmental microbiome
16.PMID: 37763321 (2023) — Validating the Nutraceutical Significance of Minor Millets by Employing Nutritional-Antinutritional Profiling. · Life (Basel, Switzerland)
17.PMID: 24318764 (2014) — The GATA and SORLIP motifs in the 3-hydroxy-3-methylglutaryl-CoA reductase promoter of Picrorhiza kurrooa for the control of light-mediated expression. · Functional & integrative genomics
18.PMID: 37900620 (2023) — In Vitro Antioxidant and Inhibitory Study of Picrorhiza kurroa (Kutki), Syzygium aromaticum (Loung), Lawsonia inermis (Henna), Rheum emodi (Revand Chini), Curcuma longa (Haldi) Against Lipid Per-Oxidation in Mice Brain and Liver. · Dose-response : a publication of International Hormesis Society
19.PMID: 32554175 (2020) — PkGPPS.SSU interacts with two PkGGPPS to form heteromeric GPPS in Picrorhiza kurrooa: Molecular insights into the picroside biosynthetic pathway. · Plant physiology and biochemistry : PPB
20.PMID: 29938416 (2018) — Mechanism Of Nephroprotection By Picrorhiza Kurroa. · Journal of Ayub Medical College, Abbottabad : JAMC
21.PMID: 36500409 (2022) — Pharmacological and Clinical Efficacy of Picrorhiza kurroa and Its Secondary Metabolites: A Comprehensive Review. · Molecules (Basel, Switzerland)
22.PMID: 38812200 (2024) — [A new cucurbitane glycoside from Picrorhiza scrophulariiflora]. · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
23.PMID: 37258151 (2023) — Hepatoprotective Principles from the Rhizomes of Picrorhiza kurroa. · Biological & pharmaceutical bulletin
24.PMID: 36166817 (2023) — Phytochemical investigation, antioxidant and anticancer activities of various Unani drugs. · Drug metabolism and personalized therapy
25.PMID: 36184806 (2022) — Iridoid glycosides from Picrorhiza genus endemic to the Himalayan region: phytochemistry, biosynthesis, pharmacological potential and biotechnological intercessions to boost production. · Critical reviews in biotechnology
26.PMID: 24522789 (2014) — An inducible NADPH-cytochrome P450 reductase from Picrorhiza kurrooa - an imperative redox partner of cytochrome P450 enzymes. · Functional & integrative genomics
27.PMID: 23105761 (2008) — Antidiabetic and antioxidant effects of Picrorhiza kurrooa rhizome extracts in diabetic rats. · Indian journal of clinical biochemistry : IJCB
28.PMID: 21772756 (2011) — Design and development of a stable polyherbal formulation based on the results of compatibility studies. · Pharmacognosy research
29.PMID: 29484024 (2018) — Herbal Compounds for the Treatment of Vitiligo: A Review. · Open access Macedonian journal of medical sciences